VCYT – Veracyte Inc.
VCYT — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
6.92
Margin Of Safety %
2
Put/Call OI Ratio
0.16
EPS Next Q Diff
-0.11
EPS Last/This Y
0.81
EPS This/Next Y
0.12
Price
32.16
Target Price
48.09
Analyst Recom
1.62
Performance Q
-26.31
Upside
-43.9%
Beta
2.02
Ticker: VCYT
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | VCYT | 33.36 | 0.18 | 0.00 | 3597 |
| 2026-03-10 | VCYT | 32.74 | 0.16 | 6.00 | 3941 |
| 2026-03-11 | VCYT | 32.43 | 0.17 | 4.67 | 3968 |
| 2026-03-12 | VCYT | 30.96 | 0.17 | 0.50 | 3977 |
| 2026-03-13 | VCYT | 30.93 | 0.17 | 0.50 | 3977 |
| 2026-03-17 | VCYT | 33.51 | 0.16 | 0.00 | 3979 |
| 2026-03-18 | VCYT | 33.3 | 0.16 | 0.00 | 3981 |
| 2026-03-19 | VCYT | 32.77 | 0.16 | 1.60 | 3985 |
| 2026-03-20 | VCYT | 31.87 | 0.16 | 0.33 | 3978 |
| 2026-03-23 | VCYT | 33.5 | 0.18 | 0.00 | 2181 |
| 2026-03-24 | VCYT | 32.95 | 0.18 | 4.00 | 2183 |
| 2026-03-25 | VCYT | 32.79 | 0.19 | 0.00 | 2193 |
| 2026-03-26 | VCYT | 32.76 | 0.18 | 0.00 | 2186 |
| 2026-03-27 | VCYT | 30 | 0.18 | 0.00 | 2208 |
| 2026-03-30 | VCYT | 30.45 | 0.18 | 0.06 | 2209 |
| 2026-03-31 | VCYT | 32.2 | 0.15 | 0.00 | 2644 |
| 2026-04-01 | VCYT | 32.44 | 0.15 | 0.00 | 2695 |
| 2026-04-02 | VCYT | 32.24 | 0.15 | 3.00 | 2695 |
| 2026-04-06 | VCYT | 32.33 | 0.15 | 0.68 | 2694 |
| 2026-04-07 | VCYT | 32.12 | 0.16 | 0.00 | 2720 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | VCYT | 33.33 | 7.5 | 34.2 | 1.65 |
| 2026-03-10 | VCYT | 32.76 | 7.5 | 34.0 | 1.65 |
| 2026-03-11 | VCYT | 32.44 | 7.5 | 34.8 | 1.65 |
| 2026-03-12 | VCYT | 30.92 | 7.5 | 30.3 | 1.65 |
| 2026-03-13 | VCYT | 32.15 | 7.5 | 40.8 | 1.65 |
| 2026-03-17 | VCYT | 33.50 | 7.5 | 38.1 | 1.65 |
| 2026-03-18 | VCYT | 33.32 | 7.5 | 35.5 | 1.65 |
| 2026-03-19 | VCYT | 32.78 | 7.5 | 9.3 | 1.65 |
| 2026-03-20 | VCYT | 31.84 | 7.5 | 8.2 | 1.65 |
| 2026-03-23 | VCYT | 33.52 | 7.5 | 15.6 | 1.65 |
| 2026-03-24 | VCYT | 32.95 | 7.5 | 9.1 | 1.65 |
| 2026-03-25 | VCYT | 32.78 | 7.5 | 10.3 | 1.65 |
| 2026-03-26 | VCYT | 32.78 | 7.5 | 10.8 | 1.65 |
| 2026-03-27 | VCYT | 29.99 | 7.5 | 2.9 | 1.65 |
| 2026-03-30 | VCYT | 30.44 | 7.5 | 12.2 | 1.65 |
| 2026-03-31 | VCYT | 32.19 | 6.9 | 16.3 | 1.65 |
| 2026-04-01 | VCYT | 32.40 | 6.9 | 11.3 | 1.65 |
| 2026-04-02 | VCYT | 32.22 | 6.9 | 10.3 | 1.65 |
| 2026-04-06 | VCYT | 32.31 | 6.9 | 11.0 | 1.65 |
| 2026-04-07 | VCYT | 32.16 | 6.9 | 10.4 | 1.65 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | VCYT | -13.66 | -3.27 | 7.78 |
| 2026-03-10 | VCYT | -13.66 | -3.27 | 7.78 |
| 2026-03-11 | VCYT | -13.66 | -3.27 | 7.06 |
| 2026-03-12 | VCYT | -13.66 | -3.27 | 7.06 |
| 2026-03-13 | VCYT | -13.66 | -3.27 | 7.06 |
| 2026-03-17 | VCYT | -13.66 | -3.11 | 7.06 |
| 2026-03-18 | VCYT | -13.66 | -3.11 | 7.06 |
| 2026-03-19 | VCYT | -13.66 | -3.11 | 7.06 |
| 2026-03-20 | VCYT | -13.66 | -3.11 | 7.06 |
| 2026-03-23 | VCYT | -13.66 | -3.11 | 7.06 |
| 2026-03-24 | VCYT | -13.56 | -3.11 | 7.06 |
| 2026-03-25 | VCYT | -13.56 | -3.11 | 6.92 |
| 2026-03-26 | VCYT | -13.56 | -3.11 | 6.92 |
| 2026-03-27 | VCYT | -13.56 | -3.11 | 6.92 |
| 2026-03-30 | VCYT | -13.56 | -3.11 | 6.92 |
| 2026-03-31 | VCYT | -13.56 | -3.11 | 6.92 |
| 2026-04-01 | VCYT | -13.56 | -3.11 | 6.92 |
| 2026-04-02 | VCYT | -13.56 | -3.11 | 6.92 |
| 2026-04-06 | VCYT | -12.41 | -3.11 | 6.92 |
| 2026-04-07 | VCYT | -12.41 | -3.11 | 6.92 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.53
Avg. EPS Est. Current Quarter
0.33
Avg. EPS Est. Next Quarter
0.42
Insider Transactions
-12.41
Institutional Transactions
-3.11
Beta
2.02
Average Sales Estimate Current Quarter
130
Average Sales Estimate Next Quarter
143
Fair Value
32.89
Quality Score
92
Growth Score
75
Sentiment Score
85
Actual DrawDown %
46.3
Max Drawdown 5-Year %
-73
Target Price
48.09
P/E
39.15
Forward P/E
17.92
PEG
7.96
P/S
4.94
P/B
1.95
P/Free Cash Flow
20.17
EPS
0.82
Average EPS Est. Cur. Y
1.65
EPS Next Y. (Est.)
1.77
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
12.83
Relative Volume
0.54
Return on Equity vs Sector %
-22.4
Return on Equity vs Industry %
-5.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.12
EBIT Estimation
10.4
◆
VCYT
Healthcare
$32.15
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
44.3
Range 1M
54.9%
Sup Dist
0.8%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-6.8%
EPS NY
8.2%
52W%
33.6%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+21.2% upside
Upside
+21.2%
Quality
92
MoS
2%
Veracyte, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 755
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
VCYT
Latest News
—
Caricamento notizie per VCYT…
stock quote shares VCYT – Veracyte Inc. Stock Price stock today
news today VCYT – Veracyte Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VCYT – Veracyte Inc. yahoo finance google finance
stock history VCYT – Veracyte Inc. invest stock market
stock prices VCYT premarket after hours
ticker VCYT fair value insiders trading